Inventor · disambiguated record
Yoram Reiter
Also filed as: REITER YORAM
22 granted patents·24 pending applications·199 citations·filing 1997–2021
95Inventor score
Top patents by PatentIndex Score
46 records- 0192US7718777B2MHC-peptide complex binding ligandsTECHNION RES & DEV FOUNDATION·Filed 2006·Granted May 18, 2010·19 cites·2 claims
- 0292US6423513B1Polynucleotides encoding protease-activatable pseudomonas exotoxin a-like proproteinsUS HEALTH·Filed 2000·Granted Jul 23, 2002·30 cites·5 claims
- 0390US7977457B2Fusion proteins, uses thereof and processes for producing sameTEVA PHARMA·Filed 2007·Granted Jul 12, 2011·13 cites·1 claims
- 0489US6992176B2Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune diseaseTECHNION RES & DEV FOUNDATION·Filed 2002·Granted Jan 31, 2006·37 cites·1 claims
- 0588US7632923B2Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereofTECHNION RES & DEV FOUNDATION·Filed 2005·Granted Dec 15, 2009·9 cites·2 claims
- 0687US7638124B2Antigen-presenting complex-binding compositions and uses thereofTECHNION RES & DEV FOUNDATION·Filed 2004·Granted Dec 29, 2009·10 cites·2 claims
- 0786US8361473B2Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseasesTECHNION RES & DEV FOUNDATION·Filed 2008·Granted Jan 29, 2013·14 cites·21 claims
- 0886US7399838B2Single chain class I major histo-compatibility complexesTECHNION RES & DEV FOUNDATION·Filed 2002·Granted Jul 15, 2008·8 cites·4 claims
- 0983US8747855B2Anti human immunodeficiency antibodies and uses thereofREITER YORAM·Filed 2009·Granted Jun 10, 2014·10 cites·11 claims
- 1078US9023348B2Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereofREITER YORAM·Filed 2009·Granted May 5, 2015·2 cites·5 claims
- 1177US9095533B2Antigen-presenting complex-binding compositions and uses thereofREITER YORAM·Filed 2009·Granted Aug 4, 2015·0 cites·6 claims
- 1277US8541185B2Method of predicting responsiveness to autologous adoptive cell transfer therapyOVED KFIR·Filed 2008·Granted Sep 24, 2013·11 cites·3 claims
- 1373US9695410B2Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptidesREITER YORAM·Filed 2011·Granted Jul 4, 2017·2 cites·8 claims
- 1472US6426075B1Protease-activatable pseudomonas exotoxin A-like proproteinsUS HEALTH·Filed 1997·Granted Jul 30, 2002·33 cites·19 claims
- 1568US2009258393A1Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating sameREITER YORAM·Filed 2009·Application pending·0 cites
- 1666US2009148925A1Single chain class I major histocompatibility complexesTECHNION RES & DEV FOUNDATION·Filed 2008·Application pending·0 cites
- 1764US2015152161A1Fusion proteins, uses thereof and processes for producing sameTECHNION RES & DEV FOUNDATION·Filed 2014·Application pending·0 cites
- 1862US2004191260A1Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereofTECHNION RES & DEV FOUNDATION·Filed 2003·Application pending·0 cites
- 1960US8354066B2Artificial receptorsTECHNION RES & DEV FOUNDATION·Filed 2007·Granted Jan 15, 2013·1 cites·13 claims
- 2060US2003223994A1MHC-peptide complex binding ligandsFiled 2003·Application pending·0 cites
- 2159US12252547B2Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of sameADICET THERAPEUTICS INC·Filed 2021·Granted Mar 18, 2025·0 cites·16 claims
- 2259US2017211076A1Fusion proteins, uses thereof and processes for producing sameTECHNION RES & DEV FOUNDATION·Filed 2017·Application pending·0 cites
- 2359US2004086960A1Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating sameFiled 2002·Application pending·0 cites
- 2457US9616112B2Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereofTECHNION RES & DEV FOUNDATION·Filed 2015·Granted Apr 11, 2017·0 cites·11 claims
- 2556US2020385441A1Immunotherapeutic composition for the treatment of cancerTECHNION RES & DEV FOUNDATION·Filed 2020·Application pending·0 cites
- 2655US2011318369A1Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune diseaseREITER YORAM·Filed 2011·Application pending·0 cites
- 2755US2011150874A1Fusion proteins, uses thereof and processes for producing sameTEVA PHARMA·Filed 2010·Application pending·0 cites
- 2853US7294701B2Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using sameTECHNION RES & DEV FOUNDATION·Filed 2003·Granted Nov 13, 2007·0 cites·1 claims
- 2953US2005287141A1Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune diseaseTECHNION RES & DEV FOUNDATION·Filed 2005·Application pending·0 cites
- 3052US2014363440A1Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseasesTECHNION RES & DEV FOUNDATION·Filed 2014·Application pending·0 cites
- 3152US2010228007A1Mhc-peptide complex binding ligandsTECHNION RES & DEV FOUNDATION·Filed 2010·Application pending·0 cites
- 3251US8022190B2Immuno-molecules containing viral proteins, compositions thereof and methods of usingTECHNION RES & DEV FOUNDATION·Filed 2002·Granted Sep 20, 2011·0 cites·8 claims
- 3350US2013101594A1Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseasesLTD TECHNION RES & DEV FOUNDATION·Filed 2012·Application pending·0 cites
- 3448US11001642B2Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of sameADICET BIO INC·Filed 2016·Granted May 11, 2021·0 cites·14 claims
- 3545US2010158927A1Antibodies, methods and kits for diagnosing and treating melanomaTECHNION RES & DEV FOUNDATION·Filed 2008·Application pending·0 cites
- 3644US8449889B2Immuno-molecules containing viral proteins, compositions thereof and methods of usingREITER YORAM·Filed 2011·Granted May 28, 2013·0 cites·10 claims
- 3743US2011033473A1Anti influenza antibodies and uses thereofREITER YORAM·Filed 2009·Application pending·0 cites
- 3840US2014170168A1Antibodies which bind soluble t-cell receptor ligandsREITER YORAM·Filed 2011·Application pending·0 cites
- 3939US11485785B2Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereofADICET BIO INC·Filed 2017·Granted Nov 1, 2022·0 cites·39 claims
- 4039US2017198046A1Compositions capable of specifically binding particular human antigen presenting molecule/ antigen complexes and uses thereofTECHNION RES & DEV FOUNDATION·Filed 2017·Application pending·0 cites
- 4139US2010062001A1Antibodies for selective apoptosis of cellsTECHNION RES & DEV·Filed 2005·Application pending·0 cites
- 4238US2008076670A1Artificial receptorsSIVAN URI·Filed 2006·Application pending·0 cites
- 4338US2013189284A1Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptidesREITER YORAM·Filed 2011·Application pending·0 cites
- 4434US2003017134A1Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancerTECHNION RES & DEV FOUNDATION·Filed 2002·Application pending·0 cites
- 4532US2019031759A1Chimeric antigen receptors and methods of their useTECHNION RES & DEV FOUNDATION·Filed 2015·Application pending·0 cites
- 4630US2018179283A1T cell receptor like antibodies having fine specificityADICET BIO INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoram Reiter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →